<!DOCTYPE html>
<html lang="en-US">
<head>

    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="theme" content="hugo-academic-group">

    
    

    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.12.4/jquery.min.js"></script>
    <script src="//js/hugo-academic-group.js"></script>

    <link rel="stylesheet" href="//css/bootstrap.min.css">
    <script src="//js/bootstrap.min.js"></script>  

    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.6.0/styles/default.min.css">

    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/github-fork-ribbon-css/0.2.2/gh-fork-ribbon.min.css" />
    
    
    <script src="//js/highlight.pack.js"></script>
    <script>hljs.initHighlightingOnLoad();</script>


    <link rel="stylesheet" href="//css/font-awesome.min.css">
    <link rel="stylesheet" href="//css/academicons.min.css">
    <link rel="stylesheet" href="//css/biaslab-font.css">
    <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:100,300,400,700|Merriweather:100,400,700|Roboto+Mono">
    <link rel="stylesheet" href="//css/hugo-academic-group.css">

    


    <link rel="shortcut icon" href="//img/favicon.ico" type="image/x-icon">
    <link rel="canonical" href="/publication/nejmoa1812836/">

    <title>Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL | Blachly Lab</title>

</head>

<body>
<div class="home-anchor" id="home"></div>



<nav class="navbar navbar-default navbar-fixed-top" id="navbar-main">
    <div class="container">

        
        <div class="navbar-header">
            <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target=".navbar-collapse" aria-expanded="false">
                <span class="sr-only">Toggle navigation</span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>

            <div class="navbar-brand">
                
                    <a class="logo" href="">
                        <img src="/img/lab_logo.png" alt="University logo"></img>
                    </a>
                
                
                 
                    
                    
                        <a href="">Blachly Lab</a>
                    
    
                
            </div>
        </div>

        
        <div class="collapse navbar-collapse" id="#navbar-collapse-1">

            
            <ul class="nav navbar-nav navbar-right">
                
                    
                        <li class="nav-item"><a data-scroll href="/#top">Home</a></li>
                    
                
                    
                        <li class="nav-item"><a data-scroll href="/research">Research</a></li>
                    
                
                    
                        <li class="nav-item"><a data-scroll href="/#publications">Publications</a></li>
                    
                
                    
                        <li class="nav-item"><a data-scroll href="/#projects">Projects</a></li>
                    
                
                    
                        <li class="nav-item"><a data-scroll href="/#members">Members</a></li>
                    
                
                    
                        <li class="nav-item"><a data-scroll href="/#posts">Blog</a></li>
                    
                
                        
                        
                        <li class="dropdown">
                            <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Join us <span class="caret"></span></a>
                            <ul class="dropdown-menu">
                              
                                <li><a href="">Internships</a></li>
                              
                                <li><a href="">Vacancies</a></li>
                              
                            </ul>
                          </li>
                    
                
                        
                        
                        <li class="dropdown">
                            <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Software <span class="caret"></span></a>
                            <ul class="dropdown-menu">
                              
                                <li><a href="https://github.com/blachlylab/dhtslib">dhtslib</a></li>
                              
                                <li><a href="https://github.com/blachlylab/fade">fade</a></li>
                              
                                <li><a href="https://github.com/blachlylab/fishnet">fishnet</a></li>
                              
                                <li><a href="https://github.com/blachlylab/maskerade">maskerade</a></li>
                              
                                <li><a href="https://github.com/blachlylab/mucor3">mucor3</a></li>
                              
                                <li><a href="https://github.com/blachlylab/nopilesum">nopilesum</a></li>
                              
                                <li><a href="https://github.com/blachlylab/recontig">recontig</a></li>
                              
                                <li><a href="https://github.com/blachlylab/SABER">SABER</a></li>
                              
                                <li><a href="https://github.com/blachlylab/swiftover">swiftover</a></li>
                              
                            </ul>
                          </li>
                    
                
                    
                        <li class="nav-item"><a data-scroll href="/#contact">Contact</a></li>
                    
                
                
            </ul>

        </div>
    </div>
</nav>



<div class="container">

    <div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

        <div class="row">
            <div class="col-sm-12">
                <div class="pub-title">
                    <h1 itemprop="name">Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL</h1>
                </div>
            </div>
        </div>
        
        <div class="row">
            <div class="col-sm-12">
                <div class="pub-authors" itemprop="author">
                    
<div itemprop="author">
        
            
                
<span class="author-name">
    
        Jennifer A. Woyach
    
</span>,
            
                
<span class="author-name">
    
        Amy S. Ruppert
    
</span>,
            
                
<span class="author-name">
    
        Nyla A. Heerema
    
</span>,
            
                
<span class="author-name">
    
        Weiqiang Zhao
    
</span>,
            
                
<span class="author-name">
    
        Allison M. Booth
    
</span>,
            
                
<span class="author-name">
    
        Wei Ding
    
</span>,
            
                
<span class="author-name">
    
        Nancy L. Bartlett
    
</span>,
            
                
<span class="author-name">
    
        Danielle M. Brander
    
</span>,
            
                
<span class="author-name">
    
        Paul M. Barr
    
</span>,
            
                
<span class="author-name">
    
        Kerry A. Rogers
    
</span>,
            
                
<span class="author-name">
    
        Sameer A. Parikh
    
</span>,
            
                
<span class="author-name">
    
        Steven Coutre
    
</span>,
            
                
<span class="author-name">
    
        Arti Hurria
    
</span>,
            
                
<span class="author-name">
    
        Jennifer R. Brown
    
</span>,
            
                
<span class="author-name">
    
        Gerard Lozanski
    
</span>,
            
                
<span class="author-name">
    
        James S. Blachly
    
</span>,
            
                
<span class="author-name">
    
        Hatice G. Ozer
    
</span>,
            
                
<span class="author-name">
    
        Brittny Major-Elechi
    
</span>,
            
                
<span class="author-name">
    
        Briant Fruth
    
</span>,
            
                
<span class="author-name">
    
        Sreenivasa Nattam
    
</span>,
            
                
<span class="author-name">
    
        Richard A. Larson
    
</span>,
            
                
<span class="author-name">
    
        Harry Erba
    
</span>,
            
                
<span class="author-name">
    
        Mark Litzow
    
</span>,
            
                
<span class="author-name">
    
        Carolyn Owen
    
</span>,
            
                
<span class="author-name">
    
        Charles Kuzma
    
</span>,
            
                
<span class="author-name">
    
        Jeremy S. Abramson
    
</span>,
            
                
<span class="author-name">
    
        Richard F. Little
    
</span>,
            
                
<span class="author-name">
    
        Scott E. Smith
    
</span>,
            
                
<span class="author-name">
    
        Richard M. Stone
    
</span>,
            
                
<span class="author-name">
    
        Sumithra J. Mandrekar
    
</span>,
            
            
                 
<span class="author-name">
    
        John C. Byrd
    
</span>
            
        
</div>

                </div>
            </div>
        </div>

        
        
        <div class="row">
            <div class="col-sm-12">
                <h3>Abstract</h3>
            </div>
        </div>
        
        <div class="row">
            <div class="col-sm-12">
                <p class="pub-abstract" itemprop="text">Ibrutinib has been approved by the Food and Drug Administration for the treatment of patients with untreated chronic lymphocytic leukemia (CLL) since 2016 but has not been compared with chemoimmunotherapy. We conducted a phase 3 trial to evaluate the efficacy of ibrutinib, either alone or in combination with rituximab, relative to chemoimmunotherapy. Patients 65 years of age or older who had untreated CLL were randomly assigned to receive bendamustine plus rituximab, ibrutinib, or ibrutinib plus rituximab. The primary end point was progression-free survival. The Alliance Data and Safety Monitoring Board made the decision to release the data after the protocol-specified efficacy threshold had been met. A total of 183 patients were assigned to receive bendamustine plus rituximab, 182 to receive ibrutinib, and 182 to receive ibrutinib plus rituximab. Median progressionfree survival was reached only with bendamustine plus rituximab. The estimated percentage of patients with progression-free survival at 2 years was 74% with bendamustine plus rituximab and was higher with ibrutinib alone (87%; hazard ratio for disease progression or death, 0.39; 95% confidence interval [CI], 0.26 to 0.58; P&lt;0.001) and with ibrutinib plus rituximab (88%; hazard ratio, 0.38; 95% CI, 0.25 to 0.59; P&lt;0.001). There was no significant difference between the ibrutinib-plusrituximab group and the ibrutinib group with regard to progression-free survival (hazard ratio, 1.00; 95% CI, 0.62 to 1.62; P=0.49). With a median follow-up of 38 months, there was no significant difference among the three treatment groups with regard to overall survival. The rate of grade 3, 4, or 5 hematologic adverse events was higher with bendamustine plus rituximab (61%) than with ibrutinib or ibrutinib plus rituximab (41% and 39%, respectively), whereas the rate of grade 3, 4, or 5 nonhematologic adverse events was lower with bendamustine plus rituximab (63%) than with the ibrutinib-containing regimens (74% with each regimen). Among older patients with untreated CLL, treatment with ibrutinib was superior to treatment with bendamustine plus rituximab with regard to progression-free survival. There was no significant difference between ibrutinib and ibrutinib plus rituximab with regard to progression-free survival. (Funded by the National Cancer Institute and Pharmacyclics; ClinicalTrials.gov number, NCT01886872.</p>
            </div>
        </div>

        <div class="row">
            <div class="col-sm-12">
                <div class="row">
                    <div class="col-xs-12 col-sm-3 pub-row-heading">Publication</div>
                    <div class="col-xs-12 col-sm-9">Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL</div>
                </div>
            </div>
        </div>
        
        <div class="visible-xs space-below"></div>

        

        <div class="row">
            <div class="col-sm-12">
                <div class="row">
                    <div class="col-xs-12 col-sm-3 pub-row-heading">Date</div>
                    <div class="col-xs-12 col-sm-9" itemprop="datePublished">
                        
                        December, 2018
                    </div>
                </div>
            </div>
        </div>

        <div class="visible-xs space-below"></div>

        <div class="row" style="padding-top: 10px">
            <div class="col-sm-12">
                <div class="row">
                    <div class="col-xs-12 col-sm-3 pub-row-heading" style="line-height:34px;">Links</div>
                    <div class="col-xs-12 col-sm-9">

                        




<a class="btn btn-primary btn-outline" href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa1812836">PDF</a>




<a class="btn btn-primary btn-outline" href="/project/research">Project</a>





                    </div>
                </div>
            </div>
        </div>
        <div class="visible-xs space-below"></div>

        <div class="space-below"></div>

        <div class="article-style"></div>

    </div>


</div>

<footer class="site-footer">
    <div class="container">
        <p class="powered-by">

            Â© Blachly Lab, 2022 &middot; 

            Partially powered by the <a href="https://github.com/gcushen/hugo-academic" target="_blank">Academic theme</a> for <a href="http://gohugo.io" target="_blank">Hugo</a>.

            <span class="pull-right"><a href="#home" id="back_to_top"><span class="button_icon"><i class="fa fa-chevron-up fa-2x" aria-hidden="true"></i></span></a></span>

        </p>
    </div>
</footer>

<script src="//cdnjs.cloudflare.com/ajax/libs/gsap/1.18.4/TweenMax.min.js"></script>
<script src="//cdnjs.cloudflare.com/ajax/libs/gsap/latest/plugins/ScrollToPlugin.min.js"></script>




<script type="text/x-mathjax-config">
 MathJax.Hub.Config({ tex2jax: { inlineMath: [['$','$'], ['\\(','\\)']] } });
</script>

<script type="text/javascript" async
        src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS_CHTML">
</script>

</body>
</html>

